Relapsing-Remitting Multiple Sclerosis
GPTKB entity
Statements (51)
Predicate | Object |
---|---|
gptkbp:instanceOf |
Multiple Sclerosis subtype
|
gptkbp:abbreviation |
gptkb:RRMS
|
gptkbp:affects |
gptkb:spinal_cord
brain |
gptkbp:associatedWith |
central nervous system
demyelination |
gptkbp:cause |
autoimmune response
|
gptkbp:characterizedBy |
episodes of neurological symptoms
periods of remission |
gptkbp:complication |
gptkb:depression
spasticity cognitive impairment disability progression |
gptkbp:diagnosedBy |
neurological examination
MRI lumbar puncture |
gptkbp:differentialDiagnosis |
gptkb:systemic_lupus_erythematosus
gptkb:neuromyelitis_optica sarcoidosis acute disseminated encephalomyelitis |
gptkbp:diseaseCourse |
relapses followed by recovery
|
gptkbp:field |
neurology
|
gptkbp:firstDescribed |
1868
|
gptkbp:gender |
more common in women
|
https://www.w3.org/2000/01/rdf-schema#label |
Relapsing-Remitting Multiple Sclerosis
|
gptkbp:ICD-10_code |
G35
|
gptkbp:onset |
20-40 years
|
gptkbp:percentageOfMSCases |
about 85%
|
gptkbp:prevalence |
most common form of MS
|
gptkbp:prognosis |
variable
|
gptkbp:progression |
may convert to Secondary Progressive MS
|
gptkbp:relatedTo |
gptkb:Primary_Progressive_Multiple_Sclerosis
Progressive-Relapsing Multiple Sclerosis Secondary Progressive Multiple Sclerosis |
gptkbp:riskFactor |
gptkb:Epstein-Barr_virus_infection
smoking genetic predisposition vitamin D deficiency |
gptkbp:subspecies |
gptkb:Multiple_Sclerosis
|
gptkbp:symptom |
fatigue
muscle weakness bladder dysfunction difficulty with coordination numbness vision problems |
gptkbp:treatment |
disease-modifying therapies
physical therapy corticosteroids |
gptkbp:分布地区 |
more common in northern latitudes
|
gptkbp:bfsParent |
gptkb:RRMS
|
gptkbp:bfsLayer |
7
|